Stock listing
AB3A Stock Price, News, Filings & Events — Sarepta Therapeutics, Inc.
Selected listing: AB3A · TRADEGATE · EUR · DE
AB3A:TRADEGATE represents Sarepta Therapeutics, Inc., a U.S.-based company dedicated to developing innovative therapies for rare genetic disorders. With a market capitalization of around €1.82 billion, Sarepta is focused on advancing treatment options for patients facing serious unmet medical needs. The company is actively involved in research and development efforts to introduce new solutions to the healthcare market. Recent news and filings highlight Sarepta's ongoing commitment to addressing these critical health challenges.
- Ticker
- AB3A:TRADEGATE
- Asset type
- Stock
- Market cap
- $1.66B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Sarepta Therapeutics, Inc. AB3A:TRADEGATE stock context
AB3A:TRADEGATE represents Sarepta Therapeutics, Inc., a U.S.-based company dedicated to developing innovative therapies for rare genetic disorders. With a market capitalization of around €1.82 billion, Sarepta is focused on advancing treatment options for patients facing serious unmet medical needs. The company is actively involved in research and development efforts to introduce new solutions to the healthcare market. Recent news and filings highlight Sarepta's ongoing commitment to addressing these critical health challenges.
Research Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for AB3A:TRADEGATE.
Sarepta Therapeutics, Inc. company profile
View the public company page for Sarepta Therapeutics, Inc. on 6ix.
Sarepta Therapeutics, Inc. news
Read company news and market updates connected to Sarepta Therapeutics, Inc..
Sarepta Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Sarepta Therapeutics, Inc..
Alternate listings
SRPT:NASDAQ
US · USD
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
S1RP34:BMFBOVESPA
BR · BRL
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
AB3A:GETTEX
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
A1J1BH:LSX
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
SRPT:BMV
MX · MXN
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
A1J1BH:LS
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
0L35:LSE
GB · USD
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
AB3A:FWB
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
SRPT:BOATS
US · USD
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
1SRPT:MIL
IT · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
SRPT:BIVA
MX · MXN
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.
AB3A:DUS
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:TRADEGATE.